| MESOBLAST LTD. |
| Australien |
| Gesundheit |
| AU000000MSB8 / A0DNPW |
| LWB (Frankfurt) |
| FRA:LWB, ETR:LWB, LWB:GR |
| - |
| https://www.mesoblast.com.. |
|
Mesoblast Limited is a biotechnology company specializing in the development of allogeneic, or off-the-shelf, cellular medicines intended for the treatment of severe and life-threatening inflammatory conditions. Leveraging a proprietary technology pl..
>Volltext.. |
| 1715.84 Mio. EUR |
| 1720.23 Mio. EUR |
| 57.2 Mio. EUR |
| -57.07 Mio. EUR |
| -83.53 Mio. EUR |
| -0.07 EUR |
| 115.37 Mio. EUR |
| 110.95 Mio. EUR |
| -62.6 Mio. EUR |
| 1.01 |
| 1011.51% |
| 10.99% |
| - |
| - |
| - |
| - |
| MESOBLAST |
| 25.04.26 |
|